Lee, I-Cheng
Tsai, Yung-Ping
Lin, Yen-Cheng
Chen, Ting-Chun
Yen, Chia-Heng
Chiu, Nai-Chi
Hwang, Hsuen-En
Liu, Chien-An
Huang, Jia-Guan
Lee, Rheun-Chuan
Chao, Yee
Ho, Shinn-Ying
Huang, Yi-Hsiang https://orcid.org/0000-0001-5241-5425
Funding for this research was provided by:
Taipei Veterans General Hospital (V111C-114, V112C-126, V109E-008-2, V109E-008-2(110))
National Science and Technology Council (MOST 108-3011-F-075-001-, 110-2221-E-A49-099-MY3, 111-2740-B-400-002-, 109-2314-B-010-034-MY3, 110-2314-B-075-052, 111-2314-B-075-055, NSTC 112-2628-B-A49-016-MY3)
Veterans General Hospitals and University System of Taiwan Joint Research Program (VGHUST113-G1-9-2)
Article History
Received: 13 May 2023
Accepted: 8 March 2024
First Online: 26 March 2024
Declarations
:
: This study was approved by the Institutional Review Board, Taipei Veterans General Hospital (IRB number: 2022-08-015AC), which complied with standards of the World Medical Association Declaration of Helsinki and current ethical guidelines.
: Due to the retrospective nature of the study, the Institutional Review Board waived the need for written informed consent. The identifying information of the enrolled subjects has been delinked and therefore authors could not access the information.
: Not applicable.
: YHH has received research grants from Gilead Sciences and Bristol-Meyers Squibb, and honoraria from Abbvie, Gilead Sciences, Bristol-Meyers Squibb, Ono Pharmaceutical, Merck Sharp & Dohme, Eisai, Eli Lilly, Ipsen, and Roche, and has served in an advisory role for Abbvie, Gilead Sciences, Bristol-Meyers Squibb, Ono Pharmaceuticals, Eisai, Eli Lilly, Ipsen, Merck Sharp & Dohme and Roche. The other authors declare no conflicts of interest.
: Lee IC, Tsai YP: data acquisition; analysis and interpretation of data; drafting of the manuscript.Tsai YP, Chen TC, Lin YC, Yen CH: implementation and analysis of all deep learning methods.Chiu NC, Liu CA, Hwang HN, Huang JG, Chau GY, Lee RC, Chao Y: data acquisition.Ho SY, Huang YH: study concept and design; obtained funding; critical revision of the manuscript for important intellectual content; study supervision.